CytoSorbents Corp (CTSO)

5.50
0.05 0.90
NASDAQ : Health Care
Prev Close 5.55
Open 5.60
Day Low/High 5.36 / 5.60
52 Wk Low/High 3.11 / 8.10
Volume 77.81K
Avg Volume 118.20K
Exchange NASDAQ
Shares Outstanding 28.13M
Market Cap 154.74M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Frost & Sullivan Lauds CytoSorbents For Leading The Critical Care Immunotherapy Segment With Its Novel Blood Purification Solution, CytoSorb®

Frost & Sullivan Lauds CytoSorbents For Leading The Critical Care Immunotherapy Segment With Its Novel Blood Purification Solution, CytoSorb®

By controlling dangerous inflammation, CytoSorb® is enabling superior outcomes in critically-ill patients, with reduced overall costs of intensive care in its sights

CytoSorbents Announces Positive REFRESH I Trial Results

Achieved the goals of this safety and feasibility study with demonstration of safe and significant reduction of toxic inflammatory mediators during complex open heart surgery

Cytosorbents Enters Oversold Territory (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents (CTSO)

Oversold Conditions For Cytosorbents (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapy was one of the hottest -- and most crowded -- areas within biotech in 2015. And 2016 looks promising.

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Immunotherapy was one of the hottest – and most crowded - areas within biotech in 2015.

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

4 Stocks Rising on Unusual Volume to Trade for Breakouts

4 Stocks Rising on Unusual Volume to Trade for Breakouts

These stocks rising on unusual volume are within range of triggering breakout trades.

Relative Strength Alert For Cytosorbents

Relative Strength Alert For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

4 Stocks Spiking on Big Volume: Arista Networks and More

4 Stocks Spiking on Big Volume: Arista Networks and More

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech columnist Adam Feuerstein answers readers' questions about health care.